masoprocol has been researched along with Waldenstrom Macroglobulinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deicher, H; Leo, R; Peest, D; Quesada, S | 1 |
1 other study(ies) available for masoprocol and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Functional and biochemical characteristics of a soluble B lymphocyte proliferation-inhibiting activity produced by bone marrow cells from multiple myeloma patients.
Topics: B-Lymphocytes; Bone Marrow; Humans; Immunosuppressive Agents; Indomethacin; Lymphocyte Activation; Masoprocol; Multiple Myeloma; Solubility; Waldenstrom Macroglobulinemia | 1995 |